— PrognomIQ to develop multi-omics tests leveraging Seer’s Proteograph product — — Seer to retain minority ownership in PrognomIQ — Redwood City, CA — Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced that it has spun out and completed […]
Dräger Safety AG & Co. KGaA today announced that after an initial investment in the company in 2018, it has now made a follow-on equity investment in Kuva Systems. The Kuva platform is a camera-based methane monitoring solution centered on color-coded video clips of invisible gas that are automatically generated when emission events are detected. […]
Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre-Seed round raised in December 2018 led by Fifty Years, the company has raised $9.2 million to date. The new investment […]
The REPAIR project aims to develop a new approach and clinically applicable method in cardiac contraction assistance. Current medical or surgical treatments cannot restore muscular contractility in heart failure and atrial fibrillation, two of the most common and serious cardiac diseases. A revolutionary approach would be to use smart materials to support or restore cardiac mechanical […]
Major Life Sciences Investors Support Company’s Vision, Strengthen Its Position as the Leader in Genome Engineering for Rapid Therapeutic Discovery, Development and Manufacturing REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and […]
Longmont, CO – KromaTiD, Inc. announced today that it was awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural variant discovery platform – dGH DSCVR™ – enabling efficient discovery of genomic structural causes of rare disease and measurement of unwanted structural rearrangements […]
aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion’s SLIM technology for biotherapeutics characterization and novel biomarker discovery. Chadds Fords, PA. — MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35 million Series B funding round. The oversubscribed round was […]
Capital raised will scale the Tapestri Platform to advance the development of precision medicine through improved biomarker discovery and drug development SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced $70 million in its Series C financing led by Novo Growth, the growth equity arm of […]
Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer. PARIS and SOUTH SAN FRANCISCO, Calif.: DNA Script today announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million. This oversubscribed round is led by […]
— Funding to accelerate development and commercial launch of Proteograph™ suite of reagents, instrument and software products to deliver on untapped promise of proteomics — Redwood City, CA — Seer, Inc., a life sciences company focused on empowering exceptional scientific outcomes through the power of rapid, deep, unbiased proteomics information, today announced that it has raised […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
